Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Seers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Age and Ageing|July 30, 2020
Phosphate metabolism and respiratory alkalosis: a forgotten lesson in COVID-19Timothy Seers, Rebecca Davenport
Archives of Disease in Childhood|May 6, 2017
Shock due to faecal impactionJi Soo Baik, Timothy Seers, Sabeena Qureshi, et al.
Open Forum Infectious Diseases|April 1, 2024
Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of OutcomeLisa Kurver, Timothy Seers, Suzanne van Dorp, et al.
Tropical Medicine & International Health : TM & IH|June 3, 2023
Zika virus infection in European travellers returning from Thailand in 2022: A GeoSentinel case seriesTimothy Seers, Camilla Rothe, Davidson H Hamer, et al.
British Journal of Hospital Medicine (London, England : 2005)|March 26, 2025
Disseminated Tuberculosis Driving Secondary Haemophagocytic Lymphohistiocytosis Following Adalimumab and Treatment for Latent TuberculosisTimothy Seers, Helen Quah, Dalia Ludwig, et al.
The Journal of Infectious Diseases|August 20, 2025
Accurate measurement of viral clearance in early phase antiviral studies in COVID-19Phrutsamon Wongnak, James A Watson, Podjanee Jittamala, et al.
The Pediatric Infectious Disease Journal|June 27, 2017
Hepatocellular Carcinoma in Perinatally Acquired HIV and HBV Coinfection: A Case ReportTimothy Seers, Debashis Sarker, Paul Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2017
Identification of targets of tumor suppressor microRNA-34a using a reporter library systemYoshiaki Ito, Atsushi Inoue, Timothy Seers, et al.
The Lancet. Infectious Diseases|October 13, 2025
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, Phrutsamon Wongnak, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Age and Ageing|July 30, 2020
Phosphate metabolism and respiratory alkalosis: a forgotten lesson in COVID-19Timothy Seers, Rebecca Davenport
Archives of Disease in Childhood|May 6, 2017
Shock due to faecal impactionJi Soo Baik, Timothy Seers, Sabeena Qureshi, et al.
Open Forum Infectious Diseases|April 1, 2024
Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of OutcomeLisa Kurver, Timothy Seers, Suzanne van Dorp, et al.
Tropical Medicine & International Health : TM & IH|June 3, 2023
Zika virus infection in European travellers returning from Thailand in 2022: A GeoSentinel case seriesTimothy Seers, Camilla Rothe, Davidson H Hamer, et al.
British Journal of Hospital Medicine (London, England : 2005)|March 26, 2025
Disseminated Tuberculosis Driving Secondary Haemophagocytic Lymphohistiocytosis Following Adalimumab and Treatment for Latent TuberculosisTimothy Seers, Helen Quah, Dalia Ludwig, et al.
The Journal of Infectious Diseases|August 20, 2025
Accurate measurement of viral clearance in early phase antiviral studies in COVID-19Phrutsamon Wongnak, James A Watson, Podjanee Jittamala, et al.
The Pediatric Infectious Disease Journal|June 27, 2017
Hepatocellular Carcinoma in Perinatally Acquired HIV and HBV Coinfection: A Case ReportTimothy Seers, Debashis Sarker, Paul Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2017
Identification of targets of tumor suppressor microRNA-34a using a reporter library systemYoshiaki Ito, Atsushi Inoue, Timothy Seers, et al.
The Lancet. Infectious Diseases|October 13, 2025
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, Phrutsamon Wongnak, et al.
Pageof 1